Premier Alternatives

ILiAD Biotechnologies

Drug Discovery · Weston, FL · Founded 2012 · Privately Held (backing)

Developer of a medical vaccine designed to prevent and offer treatment for human disease caused by Bordetella pertussis. ILiAD Biotechnologies is based in Weston, FL and was founded in 2012. It has raised $215 million across 7 recorded rounds; the latest was an $115 million Series B in Feb 2026.

Last price · $/share
—
Implied valuation
—
Total raised
$214.6M
Last round
Later Stage VC (Series B)
Feb 2026
No prints on record

No secondary trades in ILiAD Biotechnologies shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ILiAD Biotechnologies with a free account
  • ·The complete investor list: 11 names
  • ·Watch ILiAD Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where ILiAD Biotechnologies prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of ILiAD Biotechnologies stock.